2004
DOI: 10.1136/bmj.330.7481.39
|View full text |Cite
|
Sign up to set email alerts
|

Switching prescription drugs to over the counter

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
46
1

Year Published

2005
2005
2015
2015

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 60 publications
(47 citation statements)
references
References 3 publications
0
46
1
Order By: Relevance
“…Currently, the FDA can approve a change in a drug's status from prescription-only to overthe-counter if its benefits have been proved to outweigh its risks, if consumers can self-diagnose their conditions and easily understand the drug's label, and if the potential for abuse is low (Cohen, Paquette, and Cairns 2005;Jacobs 1998). These rules imply that it may be too soon to allow "over-the-counter genetic tests."…”
Section: Physician Interventionmentioning
confidence: 99%
“…Currently, the FDA can approve a change in a drug's status from prescription-only to overthe-counter if its benefits have been proved to outweigh its risks, if consumers can self-diagnose their conditions and easily understand the drug's label, and if the potential for abuse is low (Cohen, Paquette, and Cairns 2005;Jacobs 1998). These rules imply that it may be too soon to allow "over-the-counter genetic tests."…”
Section: Physician Interventionmentioning
confidence: 99%
“…28 However, involving the pharmacist more deeply in clinical decision making in favor of an OTC would require that remuneration structures account for the increased time commitment, additional training, and loss of prescription drug revenues. 22 In addition, some members of the panel thought that the availability of a nonprescription statin would have a negative effect on efforts to promote preventive lifestyle measures such as diet and exercise. 5 An OTC version of the antiobesity medication orlistat 60 mg, which the same joint panel recently endorsed, raises the same concern.…”
Section: Discussionmentioning
confidence: 99%
“…22 The United Kingdom has indicated that it is considering a list of Ͼ100 individual drugs that also may move to OTC. 23 However, the release of OTC simvastatin in the United Kingdom met its share of controversy.…”
Section: Discussionmentioning
confidence: 99%
“…25 There has even been discussion about allowing pharmacists to provide low dose statin therapies to patients without a prescription. 26 ' 27 These actions, in addition to the withdrawal of pseudoephedrine from open access over-the-counter, represent a desire for greater access to medications given only through the discretion of a pharmacist.…”
Section: Sponsoringimonitoring Agency Name(s) and Address(es) 10 Spomentioning
confidence: 99%